| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |